Worries About the New Year

At MarketWatch Jessica Marmor Shaw outlines the developments about which investors should be most concerned in 2018. They are:

  • Bitcoin crash
  • End of easy-money policies
  • NAFTA
  • Record corporate debt
  • Stock valuations
  • FAANG pullback
  • VIX spike
  • Robert Mueller
  • North Korea
  • Geopolitical risks, in general
  • More weakness for the dollar

I’ve mentioned the risks associate with the Bitcoin bubble before, particularly in the context of how much has been borrowed to purchase Bitcoins. The issue of high corporate debt is something about which I hadn’t been aware. How to reconcile that with very high corporate holdings of cash and cash equivalents? Maybe they aren’t the same companies and some are borrowing too much while others are sitting on their earnings.

Did she miss anything?

7 comments

Safe Superheroines

While I think that scholar Grant Schreve has the kernel of a good idea in his op-ed at the Washington Post, comparing today’s movie blockbusters (Wonder Woman and The Last Jedi, among the few of Hollywood’s big releases to make money this year) to Uncle Tom’s Cabin:

They gratify audiences by mirroring their own beliefs back to them — depicting white women as heroic paragons of virtue crusading for righteous causes — which, in turn, licenses viewers to avoid having either to acknowledge the far more complicated role white women are playing in our politics or to consider what other forms of racialized womanhood these heroines are occluding. So, while these films may trade on a widespread desire for transformative change, they are also replaying cultural scripts that our recent history already seems on the verge of exhausting and, in the process, foreclosing more visionary — and truly transformative — artistic and political possibilities.

This isn’t the first time in the history of American popular culture that a work of art whose white heroine was tasked with saving not only the men who surround her but also an entire social order met an unprecedented consumer demand and, as a result, had its political afterlife severely compromised.

Indeed, this cultural construct can be traced back at least a century and a half, when the U.S. public worshiped at the altar of another fictional white girl from a work even more divisive than “The Last Jedi” is proving to be.

there are some significant differences, too. First, Uncle Tom’s Cabin was the product of Harriet Beecher Stowe’s creativity and imagination alone. Important as a director might be, today’s big budget motion pictures are designed and created by committees. They are assiduously focus-grouped and tested prior to release. And second, although Uncle Tom’s Cabin attracted an enormous international audience, I seriously doubt that was Harriet Beecher Stowe’s intended market. Not so with today’s big budget extravaganzas. To succeed today half or more of a blockbuster’s box office must come from international audiences.

I think that Dr. Schreve has the causality reversed. As young, attractive white women, Diana Prince and Rey are safe. Their charm isn’t that they mirror audiences’ beliefs back to them. They’re insurance. They defuse to some degree potential activists in the U. S. because they’re women without driving away their target markets, both foreign and domestic. Oddly enough, there are lots of people especially men who find young women of extraordinary beauty attractive.

There is a reason that Wonder Woman wasn’t portrayed as a fat, black Lesbian other than fidelity to the Golden Age comic. Such a portrayal would have limited appeal in the United States and practically none at all outside the United States. Precious’s box office was $63.6 million. Wonder Woman’s box office has been $821.9 million. Kareena Kapoor’s performances have probably been seen and enjoyed by more eyeballs than any other actress in the world and she is beautiful, shapely, and quite fair complected.

There is a fact that Bollywood understands that Hollywood needs to relearn. Worldwide people like watching beautiful young men and women singing, dancing, falling in love, and having exciting adventures where everything turns out all right in the end. Those may not be the movies that Hollywood producers and directors want to make but they’re the pictures that audiences worldwide want to see.

4 comments

The Pathology

Swetha Kannan and Priya Krishnakumar tally the list of powerful men accused of sexual harassment since October 5 for the Los Angeles Times:

Fifty-one people accused of sexual harassment, assault or misconduct work in arts and entertainment.

Eighteen work in politics.

Twenty-one work in media.

Four work from the hospitality industry, including the restaurant and hotel business.

Four work in technology, sports, venture capitalism or other industries.

What conclusions can be drawn from that tally? Maybe there’s a pathology at work among American men but I don’t think you can draw that conclusion based on that evidence. The media and politics constitute a tiny fraction of American men—almost undoubtedly fewer than 1%. The conclusion that can be drawn is that there’s a pathology at work in the tiny insular worlds of the media and in American politics.

10 comments

Rose Marie, 1923-2017

Rose Marie Mazetta, better known under her stage name of Rose Marie and remembered for playing one of Rob Petrie’s co-writers on The Alan Brady Show on The Dick Van Dyke Show, has died at the age of 94. Variety reports:

Rose Marie, best known for her role as Sally Rogers on “The Dick Van Dyke Show," who had a nine-decade career in show business, died Thursday in Van Nuys, Calif. She was 94.

Publicist Harlan Boll confirmed her death.

Rose Marie was Emmy nominated three times for her work on “The Dick Van Dyke Show,” in which she played part of the writing team, led by Van Dyke’s Rob Petrie, for the fictional “Alan Brady Show.” The actress began a five-season stint as Sally Rogers in 1960.

She was a child star in vaudeville, the movies, and on the radio and later as an adult on the legitimate stage, in clubs, in Vegas, and on television. Carl Reiner was quoted as saying that she was the one and only candidate considered for the part of Sally Rogers, characterizing her as “a force of nature”. Writer Bill Persky said “she always delivered.” Dick Van Dyke hasn’t commented yet although I suspect he will.

She said of herself that she had the longest career in show business history and she was probably right. Certainly the breadth of her experience would be impossible to duplicate today.

6 comments

50 Years After

You might want to look at the editors of the Chicago Tribune’s account of 1968, shortly to be fifty years gone. They preface it with this admonition:

There’s a difference between nostalgia and sober reflection. The arrival of 2018 will bring an unusually powerful cocktail of both: It marks a half-century since 1968, one of the most consequential, dramatic years in American life.

No single event will drive the commemoration, such as Pearl Harbor in 1941 or 9/11 in 2001. What made 1968 significant was its nonstop, extraordinary tumult that resonates to this day — a riot of struggle and doubt, of assassination and rebellion, of outrage and paradox…

I can only hope that they’re wrong. I wouldn’t want to live anything like that year again. It was probably the most miserable year of my life.

What actually concerns me is that what is likely to defend us from such a “commemoration” is the incredible passivity of Americans in the 21st century.

2 comments

Should Employment Be At-Will?

“Employment at-will” is the ancient notion that employers have the right to terminate an employees employment for any reason at all, indeed, for no reason. Some form of it prevails in the United States and the United Kingdom. In an op-ed in the New York Times Moshe Marvit and Shaun Richman argue for changing to a system in which a “just cause” is needed to terminate an employee without ever actually making their case:

Republicans constantly argue that to compete, American corporations need to be treated like their European counterparts when it comes to corporate taxes — Europe has a very low average tax rate. Workers deserve a similar push to receive the job protections that their European counterparts enjoy.

A just-cause rule would give workers greater freedom to say no to requests that have nothing to do with their jobs, like “Can you pick up my dry cleaning?” or “Come up to my hotel room.” It would provide workers more power to resist unfair schedule changes, like an attempt to cancel a preapproved vacation. It would allow workers to resist mandatory overtime presented as voluntary. It would firmly place the burden on an employer to show that the reason it fired an employee had nothing to do with, say, the sick day she took to care for her child or the memo she wrote to complain about a powerful co-worker making sexual advances (three-quarters of women who have filed sexual harassment claims at work experience retaliation, according to one report).

I’m not as familiar with German law as I used to be but it used to be the case that in Germany, if their employees were Germans, employers couldn’t terminate their employees at all without paying extreme termination settlements. That had the perverse effects of encouraging German companies to hire foreigners or not hire at all.

The agenda of the op-eds authors are clear: the “just cause” laws they envision would be good for unions. Would they be good for workers? While I’m open to the idea of change, particularly in the present context in which American employees are losing their jobs because their employers have found workers from overseas who will work for less money, I wish they had articulated their case a bit more clearly. What would constitute a “just cause”? Would it be limited to protecting the presumed right to organize? Would it provide employers with the flexibility they require in a business environment in which rapid change is the norm?

5 comments

The Big Stories of 2018

What will the big stories of 2018 be?

I think that North Korea will continue to be a major topic but we’ll have no more idea of what to do about it in 2018 than we did in 2017. Since doing nothing is probably our best course of action, IMO that’s all for the good.

Syria will probably continue to be a major topic. What appears likely to happen is that the Assad government will have re-asserted control over most of the country by year’s end, in defiance of the predictions of Western pundits. DAESH appears to have collapsed as an incipient caliphate but all of those Gulf-, European- and American-based radicals will have returned home. Will there be an uptick in terrorist attacks? I think the likelihood is that there will be.

Most of the sexual abuse/harassment story has been concentrated within the infotainment sector. Will the revelations continue? Will the revelations spread?

Big as that story has been within the movie industry, it isn’t the biggest story in that industry. The bigger story is that after nearly a decade of little or no growth, total movie box office has actually declined sharply. Is Hollywood being disrupted? I think that may be one of the big stories of 2018.

In a situation that can only be deemed bizarre the Trump/Russia/collusion story may continue to be one of the biggest stories of 2018 and prove to be a “nothingburger”.

I feel confident in suggesting that the midterm elections will receive an enormous amount of attention from the news media. Will they receive as much attention from the voters or will the voters maintain their typical midterm elections torpor?

Any other ideas for the biggest stories of 2018?

6 comments

You Do What You’ve Been Trained to Do

I found this article at the New York Times on “evidence-based medicine” interesting:

Some of these critics (as well as many readers who comment on my articles) worry that guidelines line the pockets of pharmaceutical companies and radiologists by demanding more drugs and more scans. Others worry that evidence-based medicine makes it harder to get insurance companies to pay for needed care. Insurance companies worry that evidence-based recommendations put them on the hook for treatment with minimal proven value.

Everyone is a bit right here, and everyone is a bit wrong. This battle isn’t new; it has been going on for some time. It’s the old guard versus the new. It’s the patient versus the system. It’s freedom versus rationing. It’s even the individual physician versus the proclamations of a specialized elite.

Because of the tensions in that last conflict, this debate has become somewhat political.

The benefits of evidence-based medicine, when properly applied, are obvious. We can use test characteristics and results to make better diagnoses. We can use evidence from treatments to help people make better choices once diagnoses are made. We can devise research to give us the information we are lacking to improve lives. And, when we have enough studies available, we can look at them together to make widespread recommendations with more confidence than we’d otherwise be able.

When evidence-based medicine is not properly applied, though, it not only undermines its reasons for existence, but it also can lead to harm. Guidelines — and there are many — are often promoted as “evidence-based” even though they rely on “evidence” unsuited to its application. Sometimes, these guidelines are used by vested interests to advance an agenda or control providers.

There are many aspects of the debate. One of them is that physicians are like everybody else. They’re strongly predisposed to do what they’ve been trained to do and, well, 40% of active physicians are over 55. But additionally you can’t be an expert on everything and most physicians’ exposure to probability and statistics is pretty scanty—just enough to get by. That means that most must take someone else’s word for what’s evidence-based and what isn’t.

And physicians tend to resist intrusions by non-physicians into the way they practice rather strongly. I suspect that will be the future of the practice of medicine—fighting a delaying action against non-physicians telling them what to do and trying to preserve the tatters of what’s left of physician autonomy.

4 comments

KHN Doesn’t Understand Economics

File this article at Kaiser Health Network under “things that should make your blood boil”. As it reports the prices of drugs for rheumatoid arthritis really are outrageous:

Wholesale prices for Humira and Enbrel, the two most commonly used treatments for rheumatoid arthritis, known as RA, increased more than 70 percent in the past three years.

Since the first RA drug came to market a decade ago, nearly a dozen have been added. If basic economics prevailed, RA treatments and patients would have benefited from competition. But, because of industry price-setting practices, legal challenges and marketing tactics, they haven’t. The first RA drug cost $10,000 a year. It now lists for more than $40,000 — even as alternatives have entered the U.S. market.

“Competition generally doesn’t work to lower prices in branded specialty drugs,” said Peter Bach, director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes.

But the other aspect of the article that should cause alarm is how poorly the author understands microeconomics. There is no such thing as a “true price”, something she assumes in her remarks. In a genuinely free market supply and demand might determine the market clearing prices for commodities like pharmaceuticals but there is no genuinely free market in pharmaceuticals. They operate under multiple forms of monopolies. Some we call “patents”, government-granted exclusive licenses to sell a particular good or service. Patents have been extended beyond the law and beyond all reason by the willingness of the patent office to grant new patents on things that have already been patented when the patenters tinker with their products in ways that should not be patentable.

The other form of monopoly is physicians’ exclusive license to prescribe medications. That effectively precludes competition.

The solution to these problems is not to condemn economics. It is to reform our systems of intellectual property and occupational licensing to serve the public better. That is their purpose. Not benefiting patentholders and licensees.

3 comments

How Do We Avoid War With North Korea?

I wish that Colin Kahl were taking a more proactive approach in his advice on preventing war between the United States and North Korea than the advice he presents in his piece at Foreign Policy:

During the 2016 presidential campaign, when North Korea’s nuclear and missile program appeared to only threaten America’s Asian allies, then-candidate Trump seemed relatively sanguine about the danger. In fact, in an infamous interview with the New York Times, Trump appeared to suggest that South Korea and Japan should consider developing their own nuclear deterrents in order to fend for themselves instead of always turning to Uncle Sam. However, after being warned by President Barack Obama and receiving intelligence briefings on the growing direct threat to the United States emanating from Kim’s drive to develop a nuclear-tipped intercontinental ballistic missile (ICBM), Trump changed his tune. On Jan. 2, he tweeted: “North Korea just stated that it is in the final stages of developing a nuclear weapon capable of reaching parts of the U.S. It won’t happen!”

Yet, during the remainder of 2017, this is precisely what seemed to happen. North Korea conducted at least 20 missile tests this past year, including three missiles with intercontinental range. On Nov. 28, the North tested a Hwasong-15 ICBM capable of ranging the entire continental United States. Meanwhile, on Sept. 3, North Korea tested its largest nuclear weapon to date. The energy generated by the blast suggested that the device was at least 10-times greater than the nuclear bomb the United States dropped on Hiroshima in 1945. While it remains uncertain whether North Korea has yet perfected a survivable re-entry vehicle to reliably deliver a city-busting nuclear warhead via an ICBM, the rogue nation may pass that technological hurdle sometime in 2018.

As North Korea has approached Trump’s twitter red line, the president has responded with increasingly heated rhetoric and threats of war. Trump has taunted Kim, calling him “Little Rocket Man;” promised to rain down “fire and fury” and “totally destroy North Korea” if the Pyongyang threatens the United States with nuclear weapons; and declared that “military solutions are now fully in place, locked and loaded, should North Korea act unwisely.”

Painful as Donald Trump’s rhetoric is at times, let’s not delude ourselves into thinking that his rhetoric has produced the risks North Korea and China have introduced. They’ve been travelling this road for at least 25 years. Trump’s rhetoric makes it seem scarier but the main people making the situation scarier are the North Koreans.

IMO the best way for us to avoid our instigating a war with North Korea is to appreciate the difference between an issue and a risk. A risk is something that might present a problem. An issue is something that does present a problem. You put mitigation plans in place to deal with risks. You implement remediation when faced with an issue.

North Korea’s nuclear weapons are risks not issues. They don’t require immediate action and we honestly don’t know if they ever will. Treating them as issues rather the risks that they are is the surest way to make them into issues.

To my ear the key point is that we can’t live in a risk-free world but that’s what we’re trying to do.

6 comments